Pent<wbr/>oxifylline-<wbr/>d<sub>6</sub>

Pentoxifylline-d6

CAT N°: 33244
Price:

From 330.00 280.50

Pentoxifylline-d6 is intended for use as an internal standard for the quantification of pentoxifylline (Item No. 18720) by GC- or LC-MS. Pentoxifylline is a hemorrheologic agent.{57585} It increases the deformability of washed isolated human erythrocytes when used at a concentration of 100 µM.{57579} Pentoxifylline (1, 2, and 3 mM) inhibits ADP-induced platelet aggregation in isolated human whole blood.{57580} It inhibits thrombus formation induced by ADP in a hamster cheek pouch model when administered at doses of 5, 10, and 20 mg/kg.{57581} Formulations containing pentoxifylline have been used in the treatment of intermittent claudication.

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • 3,7-dihydro-3,7-di(methyl-d3)-1-(5-oxohexyl)-1H-purine-2,6-dione
  • Correlated keywords
    • 1185879-03-1 NSC 637086 NSC637086 deuterated deuterium GCMS LCMS pentoxifilline
  • Product Overview:
    Pentoxifylline-d6 is intended for use as an internal standard for the quantification of pentoxifylline (Item No. 18720) by GC- or LC-MS. Pentoxifylline is a hemorrheologic agent.{57585} It increases the deformability of washed isolated human erythrocytes when used at a concentration of 100 µM.{57579} Pentoxifylline (1, 2, and 3 mM) inhibits ADP-induced platelet aggregation in isolated human whole blood.{57580} It inhibits thrombus formation induced by ADP in a hamster cheek pouch model when administered at doses of 5, 10, and 20 mg/kg.{57581} Formulations containing pentoxifylline have been used in the treatment of intermittent claudication.

We also advise you